A small peptide, derived from 393 to 403 a.a. of AEG-1, was shown to inhibit AEG-1/SND1 interaction, and its ability to inhibit in vitro proliferation of triple-negative breast cancer cells was demonstrated [153]. The gene discussed is SND1; the disease is triple-negative breast carcinoma.